N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide

C11H18N4O2 — CID 55121391

IUPACN-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide
SMILESCCNC(C)(C)C(=O)Nc1nnc(C2CC2)o1
InChIInChI=1S/C11H18N4O2/c1-4-12-11(2,3)9(16)13-10-15-14-8(17-10)7-5-6-7/h7,12H,4-6H2,1-3H3,(H,13,15,16)
InChIKeyUXJXHERHPKHHBH-UHFFFAOYSA-N
MW238.29 g/mol
LogP1.27
Rot. Bonds5

About N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide

N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide (PubChem CID 55121391) has the molecular formula C11H18N4O2 and a molecular weight of 238.29 g/mol. Its IUPAC name is N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide.

Molecular Properties

Compound NameN-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide
PubChem CID55121391
Molecular FormulaC11H18N4O2
Molecular Weight238.29 g/mol
Exact Mass238.14
IUPAC NameN-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide
SMILESCCNC(C)(C)C(=O)Nc1nnc(C2CC2)o1
InChIInChI=1S/C11H18N4O2/c1-4-12-11(2,3)9(16)13-10-15-14-8(17-10)7-5-6-7/h7,12H,4-6H2,1-3H3,(H,13,15,16)
InChIKeyUXJXHERHPKHHBH-UHFFFAOYSA-N
XLogP1.27
TPSA80.05 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms17
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500238.29
LogP ≤ 51.27
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Acetamide, 2-(dimethylamino)-N-(5-propyl-1,3,4-oxadiazol-2-yl)-
CID 3073224
Acetamide, 2-(diethylamino)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)-
CID 3073226
Acetamide, 2-(diethylamino)-N-(5-propyl-1,3,4-oxadiazol-2-yl)-
CID 3073227
Acetamide, 2-(dipropylamino)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)-
CID 3073229
Acetamide, 2-(dipropylamino)-N-(5-propyl-1,3,4-oxadiazol-2-yl)-
CID 3073230
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(2,2,2-trifluoroethylamino)acetamide
CID 79261615
2-amino-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-3,3,3-trifluoro-2-methylpropanamide
CID 79805717
(2R,4S)-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-fluoropyrrolidine-2-carboxamide
CID 172371447
N-{5-[(1S)-1-amino-2,2-dimethylpropyl]-1,3,4-oxadiazol-2-yl}cyclopropane-carboxamide hydrochloride
CID 66949762
N-[5-[(1S)-1-amino-2,2-dimethylpropyl]-1,3,4-oxadiazol-2-yl]cyclopropanecarboxamide
CID 66949763
N-[5-(1-amino-2,2-dimethylpropyl)-1,3,4-oxadiazol-2-yl]cyclopropanecarboxamide
CID 70969126
(2R)-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)azepane-2-carboxamide;hydrochloride
CID 172371436

Frequently Asked Questions

What is the IUPAC name of N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide?
The IUPAC name of N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide (CID 55121391) is N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide.
What is the SMILES notation for N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide?
The canonical SMILES for N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide is CCNC(C)(C)C(=O)Nc1nnc(C2CC2)o1.
What is the InChIKey of N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide?
The InChIKey is UXJXHERHPKHHBH-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H18N4O2/c1-4-12-11(2,3)9(16)13-10-15-14-8(17-10)7-5-6-7/h7,12H,4-6H2,1-3H3,(H,13,15,16).
What are the key properties of N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide?
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide has a molecular weight of 238.29 g/mol, XLogP of 1.27, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(ethylamino)-2-methylpropanamide is sourced from PubChem (CID 55121391), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).